🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Accendra Health, Inc. (ACCH)
OTCMKTS · Delayed Price · Currency is USD
0.0204
+0.0009 (4.62%)
At close: Nov 20, 2026

Accendra Health Statistics

Total Valuation

Accendra Health has a market cap or net worth of 1.57 million. The enterprise value is 1.83 billion.

Market Cap1.57M
Enterprise Value 1.83B

Important Dates

The next estimated earnings date is Friday, February 19, 2027.

Earnings Date Feb 19, 2027
Ex-Dividend Date n/a

Share Statistics

Accendra Health has 76.92 million shares outstanding. The number of shares has decreased by -0.51% in one year.

Current Share Class 76.92M
Shares Outstanding 76.92M
Shares Change (YoY) -0.51%
Shares Change (QoQ) +0.28%
Owned by Insiders (%) 9.74%
Owned by Institutions (%) 68.14%
Float 56.22M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.00
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.72
EV / EBITDA 5.61
EV / EBIT 153.57
EV / FCF n/a

Financial Position

The company has a current ratio of 0.41

Current Ratio 0.41
Quick Ratio 0.20
Debt / Equity n/a
Debt / EBITDA 5.68
Debt / FCF n/a
Interest Coverage 0.10

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) 0.24%
Return on Invested Capital (ROIC) 0.84%
Return on Capital Employed (ROCE) 0.85%
Weighted Average Cost of Capital (WACC) 5.15%
Revenue Per Employee 392,578
Profits Per Employee -26,394
Employee Count6,500
Asset Turnover 0.83
Inventory Turnover 19.54

Taxes

Income Tax -25.72M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -99.25% in the last 52 weeks. The beta is 1.62, so Accendra Health's price volatility has been higher than the market average.

Beta (5Y) 1.62
52-Week Price Change -99.25%
50-Day Moving Average 0.41
200-Day Moving Average 2.08
Relative Strength Index (RSI) 17.05
Average Volume (20 Days) 7,109,538

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 3.04

Income Statement

In the last 12 months, Accendra Health had revenue of 2.55 billion and -171.56 million in losses. Loss per share was -2.24.

Revenue 2.55B
Gross Profit 1.13B
Operating Income 11.89M
Pretax Income -148.66M
Net Income -171.56M
EBITDA 242.79M
EBIT 11.89M
Loss Per Share -2.24
Full Income Statement

Balance Sheet

The company has 26.61 million in cash and 1.85 billion in debt, with a net cash position of -1.82 billion or -23.72 per share.

Cash & Cash Equivalents 26.61M
Total Debt 1.85B
Net Cash -1.82B
Net Cash Per Share -23.72
Equity (Book Value) -568.23M
Book Value Per Share -7.39
Working Capital -397.58M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -25.31 million and capital expenditures -173.81 million, giving a free cash flow of -199.12 million.

Operating Cash Flow -25.31M
Capital Expenditures -173.81M
Depreciation & Amortization 230.90M
Net Borrowing -235.70M
Free Cash Flow -199.12M
FCF Per Share -2.59
Full Cash Flow Statement

Margins

Gross margin is 44.13%, with operating and profit margins of 0.47% and -6.72%.

Gross Margin 44.13%
Operating Margin 0.47%
Pretax Margin -5.83%
Profit Margin -6.72%
EBITDA Margin 9.51%
EBIT Margin 0.47%
FCF Margin n/a

Dividends & Yields

Accendra Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield 0.51%
Shareholder Yield 0.51%
Earnings Yield -10,998.75%
FCF Yield -12,688.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Analyst Forecast

The average price target for Accendra Health is 1.40, which is 6,762.75% higher than the current price. The consensus rating is "Sell".

Price Target 1.40
Price Target Difference 6,762.75%
Analyst Consensus Sell
Analyst Count 3
Revenue Growth Forecast (3Y) -0.80%
EPS Growth Forecast (3Y) n/a

Stock Splits

The last stock split was on April 1, 2010. It was a forward split with a ratio of 1.5.

Last Split Date Apr 1, 2010
Split Type Forward
Split Ratio 1.5

Scores

Accendra Health has an Altman Z-Score of 0.26 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.26
Piotroski F-Score 4